Part of SACT user guide v4.0.1
Outcome
Introduction
This section provides additional information about the regimen outcomes.
Outcome - main table
May be multiple occurrences per submission (0..*).
|
Data Item No |
Data Item Name |
Format |
Schema Specification (M/R/O/P) |
|---|---|---|---|
|
88 |
End of Regimen Summary |
an1 |
R |
The following data items have been removed from SACT v4:
- 38 - Regimen Modification - Dose Reduction
- replaced with new section to specifically record Dose modification
- 57 - Regimen Outcome Summary - Curative (Completed as Planned)
- replaced with a single Outcome field to allow for a simpler and more accurate recording of a regimen Outcome
- 58 - Regimen Outcome Summary - Curative (Not Completed as Planned) Reason
- replaced with a single Outcome field to allow for a simpler and more accurate recording of a regimen Outcome
- 59 - Other - Regimen Outcome Summary - Curative (Not Completed as Planned) Reason
- replaced with a single Outcome field to allow for a simpler and more accurate recording of a regimen Outcome
- 60 - Regimen Outcome Summary - Non-Curative
- replaced with a single Outcome field to allow for a simpler and more accurate recording of a regimen Outcome
- 61 - Regimen Outcome Summary – Toxicity
- replaced with toxicity grade for more accurate recording
Outcome - data item description
End of Regimen Summary
This is a new data item for v4. Reason the reason for completing or stopping regimen. More than one option can be selected, where appropriate.
|
National Code |
National code definition |
|---|---|
|
1 |
Completed pre-determined number of cycles |
|
2 |
Disease Progression |
|
3 |
Toxicity |
|
4 |
Patient choice to stop treatment |
|
5 |
Organisation (Trust) issues/reason |
|
6 |
Minimal residual disease (MRD) negativity |
|
7 |
Death of patient |
|
8 |
Other |
Notes:
- 1 - Completed pre-determined number of cycles
- identifies that the patient completed the pre-determined number of cycles, and the regimen has been completed as planned
- 2 - Disease Progression
- identifies that the regimen was discontinued primarily because of disease progression
- 3 - Toxicity
- identifies that the regimen was discontinued because of treatment related toxicity without evidence of disease progression
- 5 - Organisation (Trust) issues/reason
- identifies that the regimen was discontinued primarily because of organisational issue
- 6 - Minimal Residual Disease (MRD) negativity
- MRD negative is when no cancer cells are detected, during or after treatment, on either a blood draw or a bone marrow aspiration.
Last edited: 24 June 2025 10:33 am
